Kinetic Analysis of Covalent Binding Between N-acetyl-L-cysteine and Albumin Through the Formation of Mixed Disulfides in Human and Rat Serum in Vitro

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2002 Dec 3

PMID 12458670

Citations 4

Authors

Daisuke Harada

Shinsuku Naito

Masaki Otagiri

Affiliations

Soon will be listed here.

Abstract

Purpose: Covalent binding between N-acetyl-L-cysteine (NAC) and albumin was evaluated kinetically by conducting in vitro experiments.

Method: After 14C-NAC was incubated with human or rat serum, the solution was analyzed by anion-exchange HPLC. The albumin-bound 14C-NAC was quantified by measuring the radioactivity in the albumin fraction.

Results: Ultraviolet chromatograms and/or radiochromatograms indicated the presence of a stable covalent bond between 14C-NAC and either human or rat albumin. By analyzing the time dependence of this protein binding in serum, the first-order binding and dissociation rate constants (k(on) and k(off) were obtained. The serum was treated in a CO2 incubator to avoid oxidative interference, and the initial rates were determined separately. The k(on) values obtained were 0.33 (h(-1)) and 0.48 (h(-1)) for human and rat serum, respectively. L-Cysteine was required to initiate the dissociation of 14C-NAC bound to albumin. Following the addition of appropriate amounts of L-cysteine, the k(off) values were determined to be 0.30-1.0 h(-1) and 0.54-1.4 h(-1) for human and rat serum, respectively.

Conclusions: The k(on) and k(off) values obtained for rat serum were in good agreement with the in vivo plasma protein binding kinetics of NAC in rats, indicating the reliability of this in vitro method for evaluating protein binding. No species differences in protein binding kinetics were found between human and rat serum.

Citing Articles

Targeting redox regulation to treat substance use disorder using N‐acetylcysteine.

Womersley J, Townsend D, Kalivas P, Uys J Eur J Neurosci. 2018; 50(3):2538-2551.

PMID: 30144182 PMC: 6387857. DOI: 10.1111/ejn.14130.

Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation.

Navath R, Wang B, Kannan S, Romero R, Kannan R J Control Release. 2009; 142(3):447-56.

PMID: 19896998 PMC: 2833236. DOI: 10.1016/j.jconrel.2009.10.035.

Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery.

Kurtoglu Y, Navath R, Wang B, Kannan S, Romero R, Kannan R Biomaterials. 2009; 30(11):2112-21.

PMID: 19171376 PMC: 2692182. DOI: 10.1016/j.biomaterials.2008.12.054.

Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels.

Navath R, Kurtoglu Y, Wang B, Kannan S, Romero R, Kannan R Bioconjug Chem. 2008; 19(12):2446-55.

PMID: 19053299 PMC: 2727757. DOI: 10.1021/bc800342d.

References

Sugii A, Harada K, Nishimura K, Hanaoka R, Masuda S . High-performance liquid chromatography of proteins on N-methylpyridinium polymer columns. J Chromatogr. 1989; 472(2):357-64. DOI: 10.1016/s0021-9673(00)94134-7. View

FUSE E, Tanii H, Takai K, Asanome K, Kurata N, Kobayashi H . Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humans. Cancer Res. 1999; 59(5):1054-60. View

Narazaki R, Hamada M, Harada K, Otagiri M . Covalent binding between bucillamine derivatives and human serum albumin. Pharm Res. 1996; 13(9):1317-21. DOI: 10.1023/a:1016057513490. View

Rowley D, Halliwell B . Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds. FEBS Lett. 1982; 138(1):33-6. DOI: 10.1016/0014-5793(82)80388-8. View

Himmelfarb J, McMenamin E, McMonagle E . Plasma aminothiol oxidation in chronic hemodialysis patients. Kidney Int. 2002; 61(2):705-16. DOI: 10.1046/j.1523-1755.2002.00151.x. View

Nishimura K, Harada K, Masuda S, Sugii A . High-performance liquid chromatography of serum albumins on an N-methylpyridinium polymer-based column. J Chromatogr. 1990; 525(1):176-82. DOI: 10.1016/s0378-4347(00)83391-5. View

Tyagi S, Simon S . Role of disulfide exchange in alpha 1-protease inhibitor. Biochemistry. 1992; 31(43):10584-90. DOI: 10.1021/bi00158a022. View

Harada D, Naito S, Kawauchi Y, Ishikawa K, Koshitani O, Hiraoka I . Determination of reduced, protein-unbound, and total concentrations of N-acetyl-L-cysteine and L-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography. Anal Biochem. 2001; 290(2):251-9. DOI: 10.1006/abio.2000.4980. View

Harada D, Naito S, Hiraoka I, Otagiri M . In vivo kinetic analysis of covalent binding between N-acetyl-L-cysteine and plasma protein through the formation of mixed disulfide in rats. Pharm Res. 2002; 19(5):615-20. DOI: 10.1023/a:1015349928000. View

10.

Takabayashi K, Imada T, Saito Y, Inada Y . Coupling between fatty acid binding and sulfhydryl oxidation in bovine serum albumin. Eur J Biochem. 1983; 136(2):291-5. DOI: 10.1111/j.1432-1033.1983.tb07740.x. View

11.

Olsson B, Johansson M, Gabrielsson J, Bolme P . Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol. 1988; 34(1):77-82. DOI: 10.1007/BF01061422. View

12.

Park B, Kitteringham N . Drug-protein conjugation and its immunological consequences. Drug Metab Rev. 1990; 22(1):87-144. DOI: 10.3109/03602539008991445. View

13.

Ozkan Y, Ozkan E, Simsek B . Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol. 2002; 82(3):269-77. DOI: 10.1016/s0167-5273(02)00010-4. View

14.

Joyce D . In vitro mechanism of oxidation of D-penicillamine in plasma. J Pharm Sci. 1991; 80(3):289-92. DOI: 10.1002/jps.2600800320. View

15.

Narazaki R, Harada K, Sugii A, Otagiri M . Kinetic analysis of the covalent binding of captopril to human serum albumin. J Pharm Sci. 1997; 86(2):215-9. DOI: 10.1021/js960234+. View

16.

FUSE E, Hashimoto A, Sato N, Tanii H, Kuwabara T, Kobayashi S . Physiological modeling of altered pharmacokinetics of a novel anticancer drug, UCN-01 (7-hydroxystaurosporine), caused by slow dissociation of UCN-01 from human alpha1-acid glycoprotein. Pharm Res. 2000; 17(5):553-64. DOI: 10.1023/a:1007512832006. View

17.

Narazaki R, Maruyama T, Otagiri M . Probing the cysteine 34 residue in human serum albumin using fluorescence techniques. Biochim Biophys Acta. 1997; 1338(2):275-81. DOI: 10.1016/s0167-4838(96)00221-x. View

18.

Sugii A . [Development of polymers for high performance ion-exchange chromatography and their application to analysis of human serum albumin components]. Yakugaku Zasshi. 1993; 113(5):343-55. DOI: 10.1248/yakushi1947.113.5_343. View

19.

Christodoulou J, Sadler P, Tucker A . 1H NMR of albumin in human blood plasma: drug binding and redox reactions at Cys34. FEBS Lett. 1995; 376(1-2):1-5. DOI: 10.1016/0014-5793(95)01231-2. View

20.

Hultberg B, Andersson A, Masson P, Larson M, Tunek A . Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest. 1994; 54(6):417-22. DOI: 10.3109/00365519409085464. View